Table 2.
Cut-off value | Sensitivity (95% Cl) | Specificity (95% Cl) | Diagnostic OR (95%Cl) | |
---|---|---|---|---|
0–4scoring system | 0.75 (0.71–0.79) | 0.93 (0.90–0.95) | 71.26 (42.29–120.09) | |
El Miedany et al.10 | ≥1 | 0.94 (0.82–0.99) | 0.95 (0.83–0.99) | 278.67 (44.21–1756.56) |
Niemela et al.2 | ≥1 | 0.78 (0.58–0.91) | 0.94 (0.85–0.99) | 59.50 (13.60–260.37) |
Theander et al.25 | ≥2 | 0.52 (0.42–0.62) | 0.98 (0.91–1.00) | 61.60 (8.22–461.650) |
Baldini et al.27 | ≥2 | 0.66 (0.51–0.79) | 0.98 (0.91–1.00) | 108.71 (13.83–854.74) |
Zhou et al.31 | ≥2 | 0.62 (0.50–0.73) | 0.98 (0.89–1.00) | 78.22 (10.20–600.03) |
Chen et al.32 | ≥1 | 0.92 (0.81–0.98) | 0.92 (0.81–0.98) | 135.13 (31.88–572.78) |
Qi et al.33 | ≥2 | 0.90 (0.84–0.95) | 0.83 (0.75–0.90) | 47.06 (21.93–100.97) |
0–16 scoring system | 0.84 (0.81–0.87) | 0.88 (0.85–0.91) | 46.3 (19.95–107.44) | |
Salaffi et al.16 | ≥6 | 0.75 (0.64–0.84) | 0.84 (0.74–0.91) | 15.50 (7.04–34.11) |
Xu et al.20 | ≥8 | 0.93 (0.81–0.99) | 0.97 (0.88–1.00) | 389.50 (62.25–2437.01) |
Milic et al.23 | ≥7 | 0.86 (0.79–0.91) | 0.94 (0.83–0.99) | 94.00 (26.68–331.22) |
Zhang et al.28 | ≥7 | 0.80 (0.71–0.87) | 0.93 (0.83–0.98) | 53.00 (17.24–162.95) |
Lin et al.29 | ≥6 | 0.80 (0.65–0.90) | 0.78 (0.64–0.88) | 13.79 (5.11–37.19) |
Qi et al.33 | ≥5 | 0.90 (0.84–0.95) | 0.87 (0.79–0.93) | 63.16 (28.34–140.75) |
0–48 scoring system | 0.75 (0.70–0.80) | 0.95 (0.91–0.97) | 66.07 (33.73–129.42) | |
Hocevar et al.13 | ≥17 | 0.59 (0.46–0.71) | 0.99 (0.95–1.00) | 105.71 (24.15–462.76) |
Milic et al.18 | ≥19 | 0.65 (0.56–0.74) | 1.00 (0.88–1.00) | 107.16 (6.36–1804.92) |
Zhang et al.28 | ≥15 | 0.89 (0.81–0.94) | 0.84 (0.72–0.93) | 41.33 (16.28–104.95) |
Lin et al.29 | ≥17 | 0.91 (0.78–0.97) | 0.92 (0.81–0.98) | 115.00 (27.00–489.88) |
OR = odd ratio.